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Obstructive sleep apnoea syndrome (OSA) is a common condition 
in childhood, affecting ~1 - 3% of children, and can result in severe 
complications if left untreated.[1] OSA is defined as a disorder of 
breathing during sleep characterised by prolonged partial upper 
airway obstruction or intermittent complete obstruction that disturbs 
normal ventilation during sleep and normal sleep patterns.[1] While 
otherwise healthy children with adenotonsillar hypertrophy form the 
largest group of children with OSA, other high-risk groups include 
children with craniofacial malformations, anatomical narrowing of 
the upper airways, neuromuscular diseases or obesity, children who 
were premature babies and children with genetic disorders such as 
Down syndrome.[2]
A diagnosis of OSA is important in order to prevent complications 
of the condition, including failure to thrive, neurocognitive deficits, 
hyperactivity and cardiovascular sequelae such as pulmonary 
hypertension. Early diagnosis of OSA is important to guide appropriate 
treatment and interventions and to monitor the effectiveness of 
subsequent interventions.[2]
Adenotonsillectomy is recommended as first-line treatment of 
patients with symptomatic adenotonsillar hypertrophy. However, 
resources for this procedure are often scarce in resource-constrained 
settings, resulting in long surgical waiting lists. Prioritising patients 
who need urgent surgical intervention is therefore necessary. 
However, this is difficult without reliable objective evidence of OSA, 
as symptom-based questionnaire screening has been shown to be 
unreliable at predicting OSA.[1,3] Furthermore, knowledge of OSA 
severity is important for planning perioperative care and reducing 
perioperative complications.[4]
Screening for OSA symptoms is recommended at every routine 
health visit. This includes inquiring about snoring or symptoms 
of OSA and identification of underlying risk factors or medical 
conditions associated with OSA.[5] Polysomnography (PSG) remains 
the recommended gold standard for the diagnosis of OSA.[5] However, 
PSG is expensive and labour intensive, requires specialised staff and 
is not available in resource-limited settings, including South Africa 
(SA). Ambulatory or in-hospital respiratory polygraphy sleep studies 
are gaining acceptability as an alternative to PSG. However, this 
technology also requires specialised equipment and expertise.[6,7]
The combination of overnight pulse oximetry and the McGill 
oximetry score (MOS) is a reliable screening tool for moderate to 
severe OSA.[4,8,9] Overnight pulse oximetry is an accessible, simple 
and cost-effective alternative to PSG and may assist in prioritising 
children for operative interventions where resources are scarce.
Objectives
Red Cross War Memorial Children’s Hospital (RCWMCH), a 
tertiary paediatric hospital in the Western Cape Province, SA, 
introduced overnight oximetry as a screening tool for OSA in 2012 
with the aim of prioritising children requiring urgent intervention. 
We studied the spectrum of OSA severity and ‘real-life’ diagnostic 
utility of overnight oximetry as a tool for the diagnosis of OSA in 
children at RCWMCH.
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Background. Obstructive sleep apnoea (OSA) is common in children yet often overlooked, as symptom-based screening is unreliable. 
Polysomnography is regarded as the gold standard for the diagnosis of OSA, but is not widely available in South Africa (SA). Overnight 
oximetry is a validated screening tool for OSA.
Objectives. To describe the impact and utility of overnight oximetry at a tertiary children’s hospital in SA.
Methods. A retrospective descriptive study was conducted of patients screened for OSA by overnight oximetry at a paediatric referral 
hospital from December 2012 to December 2014. Clinical data were retrieved from the oximetry database and medical records. Recordings 
of ≥6 hours were considered adequate and included in the study. OSA severity was determined using the McGill score. Details on 
management and outcome were documented.
Results. Oximetry studies in 137 of 153 patients were suitable for analysis (88 males (64.2%), median age 31.4 months (interquartile range 
(IQR) 15.8 - 65.8). Adenotonsillar hypertrophy was common (n=97, 70.8%), and 65 children (47.4%) had two or more underlying OSA risk 
factors. McGill’s score classified patients as follows: no/mild OSA n=55 (40.1%), moderate OSA n=23 (16.8%), severe OSA n=23 (16.8%) 
and very severe OSA n=36 (26.3%). Male gender, adenotonsillar hypertrophy and a lower weight-for-age z-score (–1.3 v. –0.7; p=0.038) were 
associated with severe to very severe OSA. Seventy-eight children (56.9%) were referred for surgery, 33 (24.1%) receiving urgent surgery 
within a median of 6 days (IQR 4 - 12). In contrast, 59 children (43.1%) with suspected OSA did not require surgical intervention.
Conclusions. Overnight oximetry is a simple low-cost tool to assess severity of OSA and prioritise appropriate OSA management in 
resource-constrained settings such as SA.
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Methods
Study design and setting
A retrospective descriptive study was conducted of all patients 
1 - 13 years of age screened with overnight oximetry for OSA by 
the pulmonology service at RCWMCH from 1 December 2012 to 
31 December 2014. Approval to conduct the study was obtained from 
the Human Research Ethics Committee of the University of Cape 
Town (ref. no. 618/2015). Informed consent from participants was 
waived and permission to conduct the study was obtained from the 
hospital management.
Sleep study referral forms with check boxes containing relevant 
clinical information and an electronic results database of all 
oximetry studies performed during the study period were retrieved 
to identify eligible participants for the study. Children with cyanotic 
congenital heart disease, chronic lung diseases (excluding well-
controlled asthma) and oximetry recordings with <6 hours of 
analysable data were excluded. In addition, only the first oximetry 
study was included if patients had more than one recording during 
the study period.
Data collection
Information relating to demographics, underlying comorbidity, 
symptoms as reported by caregivers, nutritional status (World Health 
Organization weight-for-age z-scores, body mass index) and likely 
cause(s) of OSA were documented by reviewing the medical records 
and referral form information.
Overnight oximetry
Patients with suspected OSA were admitted electively to a dedicated 
polysomnography room in a medical ward for unsupervised overnight 
oximetry. Oximetry studies performed in other wards of the hospital 
during hospitalisation were also included. Caregivers were required 
to stay with their child during the study and received a demonstration 
on how to operate the monitor.
Overnight oximetry was performed using portable Nonin 2500 
(Nonin Medical Inc., USA) pulse oximeters, which have built-in data 
memory capacity of 48 hours of continuous recording with 4-second 
averaging intervals. Overnight recordings were downloaded via 
cable with nVision data management software (Nonin Medical Inc.). 
Graphical and tabulated automated oximetry trend reports were 
generated for each study.
Classification of OSA severity with the MOS
The MOS is a widely adopted tool that has been validated with 
polysomnography to classify OSA into no/mild, moderate or severe 
categories. Severity classification of OSA is based on the frequency 
and depth/nadir of the desaturations and the number of desaturation 
clusters, defined as periods of desaturation (≥5 drops ≥4% from 
baseline) within a 10 - 30-minute period (Table 1).[4,8] Results of 
overnight oxygen saturation trend graphs were manually analysed for 
quality and eligibility by the lead investigator (NA), who calculated 
the MOS.
Treatment outcomes
Medical records were reviewed to document which medical 
interventions were implemented after the overnight oximetry 
study. Interventions were classified as surgical or non-surgical. 
Non-surgical interventions included intranasal corticosteroids, 
antihistamines, leukotriene antagonists and non-invasive positive-
pressure ventilation. The time to surgery (in days) was recorded.
Statistical analysis
Data were analysed by standard statistical methods using Stata 
version 11 (StataCorp, USA). For descriptive statistics, continuous 
variables were expressed as means (standard deviations) for normally 
distributed variables or medians and interquartile ranges (IQRs). 
The Mann-Whitney U-test was used for comparing non-normally 
distributed measures and the t-test for normally distributed measures. 
Categorical variables were compared using the χ2 test.
Results
Demographic and clinical characteristics
A total of 153 oximetry recordings were identified, of which 137 were 
suitable for analysis. Demographics, reported symptom frequency 
and prevalence of underlying medical conditions or OSA risk factors 
are presented in Table 2. The median age was 31.4 months (IQR 15.8 - 
65.8), with a greater number of males than females (64.2% v. 35.8%). 
A history of snoring and parental concern about breathing during 
sleep were commonly reported (81.0% and 72.3%, respectively). 
Adenotonsillar hypertrophy was the most common underlying risk 
factor for OSA (n=97, 70.8%), and 65 children (47.4%) had two or 
more underlying risk factors associated with OSA.
OSA severity
MOSs are presented in Fig. 1: 55 patients (40.1%) had no/mild 
OSA, 23 (16.8%) moderate OSA, 23 (16.8%) severe OSA and 36 
(26.3%) very severe OSA. The median nadir oxygen saturation for 
mild to moderate OSA compared with severe to very severe OSA 
was 80% (IQR 65 - 84) v. 64% (IQR 50 - 74) (p<0.001). There were 
no significant differences in reported symptoms in children with 
Table 1. McGill oximetry score and classification of OSA severity[4]
McGill score Desaturations ≤90%, n Desaturations ≤85%, n Desaturations ≤80%, n Desaturation clusters, n OSA severity
1 <3 0 0 <3 No or mild OSA
2 ≥3 ≤3 0 ≥3 Moderate
3 ≥3 >3 ≤3 ≥3 Severe
4 ≥3 >3 >3 ≥3 Very severe
OSA = obstructive sleep apnoea.
 
50
40
30
20
10
0
No/mild              Moderate               Severe             Very severe
Pa
tie
nt
s, 
%
Category
Fig. 1. Categories of obstructive sleep apnoea severity determined by the 
McGill oximetry score (N=137).
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mild to moderate OSA compared with severe to very severe OSA. 
Male gender, adenotonsillar hypertrophy and a lower weight-for-age 
z-score (–1.3 v. –0.7; p=0.038) were significant associations with 
severe to very severe OSA (Table 3).
Interventional outcomes
A new non-surgical intervention was initiated in response to the 
oximetry study in 52 children (38.0%), 32/78 (41.0%) with mild 
to moderate OSA and 20/59 (33.9%) with severe to very severe 
OSA. Seventy-eight children (56.9%) were referred for surgery 
(mostly for adenotonsillectomy); 33 (24.1%) required urgent surgical 
intervention, almost all (30/33, 90.9%) in the severe to very severe 
OSA group. The median time to urgent surgery in the severe to very 
severe group was 6 days (IQR 4 - 12). In contrast, 59 children (43.1%) 
with suspected OSA did not require surgical intervention, 47/78 
(60.2%) with mild to moderate OSA and 12/59 (20.3%) with severe to 
very severe OSA. Non-invasive nocturnal ventilation or conservative 
management was initiated in children with severe or very severe OSA 
in whom adenotonsillectomy or tracheostomy was not indicated or 
appropriate.
Discussion
This study reports the initial ‘real-life’ experience and impact of 
implementing an overnight oximetry OSA screening protocol in a 
public sector referral hospital in SA. This study is novel, as oximetry 
is not widely available or practised in SA, where OSA diagnosis and 
management is an important but neglected child health concern. 
Furthermore, this study demonstrates the feasibility and clinical 
value of oximetry in settings without PSG to rapidly diagnose 
severe-spectrum OSA in children who need urgent intervention, 
which in our study was nearly half of all patients. As has been 
reported elsewhere, simple symptom-based screening in our study 
was unhelpful in distinguishing severe-spectrum OSA from less 
severe OSA, confirming the need for objective evaluation of children 
with suspected OSA in order to prioritise surgery for those who need 
it most. Equally importantly, oximetry identified non-severe OSA 
in over half of all referred children, thus sparing them unnecessary 
surgery and permitting prioritisation of more urgent cases.
The association of lower weight and adenotonsillar hypertrophy 
with severe OSA in our study confirms previously reported 
findings. A meta-analysis of studies measuring growth and growth 
biomarkers (e.g. insulin-like growth factor 1 and 3) before and 
after adenotonsillectomy showed significantly improved variables 
and growth after surgery.[10] Clinicians should therefore consider 
Table 2. Patient demographic and clinical characteristics
Variable
Patients, N 137
Demographic characteristics
Age (months), median (IQR) 31.4 (15.8 - 65.8)
Gender, n (%)
Male 88 (64.2)
Female 49 (35.8)
Clinical characteristics and reported symptoms
 Weight-for-age z-score, median (IQR) 
(n=126)
–0.9 (–1.9 - 0.2)
BMI, median (IQR) (n=101) 16.4 (14.8 - 17.8)
Snoring, n (%) 111 (81.0)
Parental concern, n (%) 99 (72.3)
Apnoea, n (%) 77 (56.2)
Frequent awakenings, n (%) 15 (10.9)
Underlying OSA risk factors
Adenotonsillar hypertrophy 97 (70,8)
Neuromuscular disorders 22 (16.1)
Facial skeletal abnormalities 21 (15.3)
Obesity 14 (10.2)
Down syndrome 12 (8.8)
Prematurity 13 (9.5)
Cerebral palsy 10 (7.3)
IQR = interquartile range; BMI = body mass index; OSA = obstructive sleep apnoea.
Table 3. Patient characteristics and severity of OSA (N=137)
Variable Mild/moderate Severe/very severe p-value
Patients, N (%) 78 (56.9) 59 (43.1)
Patient characteristics
Age (months), median (IQR) 34.4 (14.9 - 69.3) 30.6 (16.9 - 58.9) 0.823
Gender, n (%) 0.011
Male 43 (55.1) 45 (76.3)
Female 35 (44.9) 14 (23.7)
Weight-for-age z-score, median (IQR) (n=126) –0.7 (–1.7 - 0.5) –1.3 (–2.3 - –0.4) 0.038
BMI, median (IQR), (n=101) 16.9 (14.9 - 21.5) 16.0 (14.8 - 17.2) 0.195
Apnoea, n (%) 39 (50.0) 38 (64.4) 0.092
Snoring, n (%) 63 (80.8) 48 (81.3) 0.931
Frequent awakenings, n (%) 9 (11.6) 6 (10.2) 0.799
Parental concern, n (%) 52 (66.7) 47 (79.7) 0.093
Adenotonsillar hypertrophy, n (%) 48 (61.6) 49 (83.1) 0.006
Neuromuscular disorders, n (%) 12 (15.4) 10 (16.9) 0.805
Facial skeletal abnormalities, n (%) 10 (12.8) 11 (18.6) 0.349
Obesity, n (%) 11 (14.1) 3 (5.1) 0.096
Cerebral palsy, n (%) 6 (7.7) 4 (6.8) 1.000
Down syndrome, n (%) 9 (11.6) 3 (5.1) 0.232
Prematurity, n (%) 6 (7.7) 7 (11.9) 0.409
OSA = obstructive sleep apnoea; IQR = interquartile range; BMI = body mass index.
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OSA when investigating children with unexplained poor growth. In 
contrast, obesity, a known risk factor for OSA, was not an important 
association in our study. However, the prevalence of obesity in this 
referred population was low, which may reflect referral patterns at our 
institution, which prioritised young children and children with other 
significant underlying OSA risk factors. It is unclear why children of 
male gender were more commonly referred in our study, or why male 
gender was associated with severe OSA. A higher prevalence of OSA 
in prepubertal males is less evident than in adults.[11]
Overnight oximetry and the MOS has been demonstrated in 
numerous studies to be a valid screening tool for detecting OSA, 
and its performance compared with PSG improves with increasing 
severity of OSA.[9] In a landmark study by Brouillette et al.,[12] 
abnormal oximetry (MOS ≥2) had a positive predictive value of 
97% in diagnosing PSG-confirmed OSA with an apnoea-hypopnea 
index (AHI) >1. However, sensitivity was low (43%), indicating 
that a negative oximetry screen using MOS does not rule out OSA. 
Lowering the oximetry threshold (2 desaturation clusters and 1 
desaturation event <90%) improves sensitivity and negative predictive 
values to 86% and 90%, respectively.[13] The oxygen desaturation 
index (ODI), a score that averages the number of desaturation events 
(drop of oxygenation saturation ≥4% from baseline) per hour may 
also be useful to screen for OSA.[9] The MOS or ODI in combination 
with clinically based screening questionnaires can further improve 
the diagnostic accuracy of oximetry in OSA.[14-16] More recently, the 
development of automated signal processing algorithms of remotely 
performed single-channel overnight oximetry recordings has shown 
high correlation with the AHI in habitually snoring children. [17] 
Together with oximetry applications on smart mobile phones, 
advancements in technology will soon permit wide-scale low-cost 
ambulatory OSA screening and diagnosis.[18]
Oximetry has several limitations, however, including low sensitivity 
to diagnose mild-spectrum OSA and inability to distinguish 
obstructive from central apnoea or hypoventilation. Furthermore, 
the MOS has been based mostly on children with adenotonsillar 
hypertrophy who have a high pre-test probability of OSA, not 
children with underlying conditions associated with central apnoea 
or hypoventilation. Nevertheless, overnight oximetry can diagnose 
moderate to severe OSA accurately and allows prioritisation of scarce 
interventions for those children who need it most urgently. The 
childhood adenotonsillectomy trial (CHAT) has provided evidence 
for the benefit of adenotonsillectomy in mild OSA.[19] The CHAT trial 
also documented a group of children who had complete resolution of 
PSG-diagnosed mild OSA which was predicted by a low baseline AHI 
and normal waist circumference, or low Pediatric Sleep Questionnaire 
and snoring scores.[20] Watchful waiting with appropriate medical 
intervention in children with oximetry-diagnosed mild OSA is 
therefore an acceptable strategy in settings with long waiting lists for 
adenotonsillectomy.
Study limitations
Our study has several limitations. First, the retrospective design 
did not allow thorough or precise interrogation of the clinical 
presentation and symptoms at the time of oximetry studies. Second, 
the referred population in this cohort at a tertiary referral hospital 
is biased towards more severe and complex cases of OSA, and many 
of the patients had additional underlying OSA risk factors. The 
results of our study therefore do not represent otherwise healthy 
children with habitual snoring, which is more common in the general 
population. Lastly, owing to resource constraints and the study 
design, we could not report follow-up outcomes or repeat oximetry 
studies in those children with mild to moderate OSA who did not 
have surgery. It would be expected that some had persistent OSA that 
required further intervention.
Conclusions
The combination of overnight oximetry and the MOS is a feasible 
and useful means of diagnosing OSA and determining OSA severity 
in children with a wide range of underlying OSA risk factors and 
underlying diagnoses. Overnight oximetry should be widely adopted 
and implemented in SA as a low-cost tool to screen for OSA in 
children.
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